|
1
|
Dopamine-mediated regulation of corticostriatal synaptic plasticity.
|
Trends Neurosci
|
2007
|
3.64
|
|
2
|
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease.
|
J Neurosci
|
2011
|
1.76
|
|
3
|
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap.
|
Lancet Neurol
|
2010
|
1.50
|
|
4
|
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.
|
J Neurosci
|
2002
|
1.40
|
|
5
|
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia.
|
J Neurosci
|
2006
|
1.34
|
|
6
|
Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression.
|
J Neurosci
|
2009
|
1.16
|
|
7
|
Plasticity and repair in the post-ischemic brain.
|
Neuropharmacology
|
2008
|
1.16
|
|
8
|
Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory.
|
Behav Brain Res
|
2008
|
1.15
|
|
9
|
Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease.
|
J Neurosci
|
2011
|
1.14
|
|
10
|
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors.
|
J Neurosci
|
2004
|
1.13
|
|
11
|
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.
|
Lancet Neurol
|
2006
|
1.11
|
|
12
|
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors.
|
Neuropsychopharmacology
|
2002
|
1.10
|
|
13
|
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction.
|
Exp Neurol
|
2009
|
1.09
|
|
14
|
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission.
|
Neuropharmacology
|
2007
|
1.07
|
|
15
|
Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders.
|
Trends Pharmacol Sci
|
2008
|
1.07
|
|
16
|
Molecular mechanisms underlying levodopa-induced dyskinesia.
|
Mov Disord
|
2008
|
1.06
|
|
17
|
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease.
|
Lancet Neurol
|
2013
|
0.99
|
|
18
|
Tissue plasminogen activator is required for corticostriatal long-term potentiation.
|
Eur J Neurosci
|
2002
|
0.99
|
|
19
|
Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias.
|
Neurobiol Aging
|
2011
|
0.97
|
|
20
|
Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition.
|
J Neurosci
|
2010
|
0.97
|
|
21
|
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease.
|
Brain
|
2012
|
0.96
|
|
22
|
Mitochondria and the link between neuroinflammation and neurodegeneration.
|
J Alzheimers Dis
|
2010
|
0.96
|
|
23
|
Synaptic dysfunction in Parkinson's disease.
|
Biochem Soc Trans
|
2010
|
0.95
|
|
24
|
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism.
|
J Neurochem
|
2003
|
0.93
|
|
25
|
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia.
|
Stroke
|
2006
|
0.91
|
|
26
|
New synaptic and molecular targets for neuroprotection in Parkinson's disease.
|
Mov Disord
|
2012
|
0.89
|
|
27
|
Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease.
|
J Neurosci
|
2012
|
0.87
|
|
28
|
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease.
|
Neurosci Lett
|
2006
|
0.86
|
|
29
|
Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study.
|
Purinergic Signal
|
2007
|
0.86
|
|
30
|
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression.
|
Proc Natl Acad Sci U S A
|
2012
|
0.86
|
|
31
|
Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits.
|
Parkinsonism Relat Disord
|
2007
|
0.86
|
|
32
|
BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior.
|
Nat Commun
|
2013
|
0.85
|
|
33
|
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice.
|
Eur J Neurosci
|
2009
|
0.85
|
|
34
|
Striatum-hippocampus balance: from physiological behavior to interneuronal pathology.
|
Prog Neurobiol
|
2011
|
0.84
|
|
35
|
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
|
Biol Psychiatry
|
2009
|
0.84
|
|
36
|
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease.
|
Mol Cell Neurosci
|
2004
|
0.84
|
|
37
|
Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice.
|
Neurobiol Aging
|
2011
|
0.84
|
|
38
|
Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery.
|
Neurobiol Dis
|
2007
|
0.84
|
|
39
|
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition.
|
J Neurosci
|
2008
|
0.84
|
|
40
|
Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases.
|
Biochim Biophys Acta
|
2009
|
0.83
|
|
41
|
Plastic abnormalities in experimental Huntington's disease.
|
Curr Opin Pharmacol
|
2006
|
0.83
|
|
42
|
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment.
|
Biol Psychiatry
|
2010
|
0.83
|
|
43
|
Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
|
Exp Neurol
|
2011
|
0.82
|
|
44
|
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTP.
|
Exp Neurol
|
2010
|
0.81
|
|
45
|
A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation.
|
PLoS One
|
2012
|
0.81
|
|
46
|
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition.
|
Eur J Pharmacol
|
2006
|
0.80
|
|
47
|
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum.
|
Neurobiol Dis
|
2002
|
0.80
|
|
48
|
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission.
|
J Cereb Blood Flow Metab
|
2012
|
0.79
|
|
49
|
N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons.
|
J Biol Chem
|
2012
|
0.78
|
|
50
|
The endocannabinoid system in Parkinson's disease.
|
Curr Pharm Des
|
2008
|
0.78
|
|
51
|
Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism.
|
Proc Natl Acad Sci U S A
|
2013
|
0.78
|
|
52
|
Θ-burst stimulation and striatal plasticity in experimental parkinsonism.
|
Exp Neurol
|
2012
|
0.78
|
|
53
|
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia.
|
Parkinsons Dis
|
2012
|
0.77
|
|
54
|
TrkB/BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid.
|
Neuropsychopharmacology
|
2010
|
0.77
|
|
55
|
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism.
|
Neuropharmacology
|
2008
|
0.77
|
|
56
|
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity.
|
Exp Neurol
|
2009
|
0.77
|
|
57
|
L-3,4-dihydroxyphenylalanine-induced sprouting of serotonin axon terminals: A useful biomarker for dyskinesias?
|
Ann Neurol
|
2010
|
0.76
|
|
58
|
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases.
|
Neurosci Lett
|
2006
|
0.76
|
|
59
|
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area.
|
Stroke
|
2007
|
0.76
|
|
60
|
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum.
|
Exp Neurol
|
2006
|
0.76
|
|
61
|
Direct and indirect pathways in levodopa-induced dyskinesia: a more complex matter than a network imbalance.
|
Mov Disord
|
2010
|
0.75
|
|
62
|
Prenatal stress and hippocampal BDNF expression: a fading imperative.
|
J Physiol
|
2012
|
0.75
|